A review of vinorelbine in the treatment of breast cancer

GH Domenech, CL Vogel - Clinical breast cancer, 2001 - Elsevier
As combinations and sequences of anthracyclines and taxanes increasingly become
standard adjuvant treatment for early breast cancer, a major need for new treatment options …

Antiblastic drug combinations with ifosfamide: an update

F Fulfaro, MR Valerio, G Badalamenti, N Gebbia… - Oncology, 2003 - karger.com
Ifosfamide is an alkylating agent that is widely used in the treatment of various neoplasms,
such as sarcomas, lymphomas, pediatric malignancies, germ cell tumors, lung, breast and …

[PDF][PDF] Phase II Study of Vinorelbine Plus Ifosfamide in Patients with Taxane-resistant Metastatic Breast Cancer

S Lee, SY Oh, HC Kwon, SH Kim… - Journal of Breast …, 2009 - synapse.koreamed.org
Purpose: The patients with metastatic breast cancer are routinely exposed to taxane and
anthracycline as neoadjuvant, adjuvant, and palliative chemotherapeutic agents. This study …